PRICE T ROWE ASSOCIATES INC /MD/ - CEREVEL THERAPEUTICS HLDNG I ownership

CEREVEL THERAPEUTICS HLDNG I's ticker is CEREW and the CUSIP is 15678U102. A total of 38 filers reported holding CEREVEL THERAPEUTICS HLDNG I in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
PRICE T ROWE ASSOCIATES INC /MD/ ownership history of CEREVEL THERAPEUTICS HLDNG I
ValueSharesWeighting
Q2 2021$3,182,000
+221.7%
223,127
-4.8%
0.00%
Q1 2021$989,000
-25.3%
234,2660.0%0.00%
Q4 2020$1,324,000234,2660.00%
Other shareholders
CEREVEL THERAPEUTICS HLDNG I shareholders Q4 2020
NameSharesValueWeighting ↓
Affinity Asset Advisors, LLC 72,466$312,0000.11%
HIGHBRIDGE CAPITAL MANAGEMENT LLC 459,215$1,979,0000.08%
Monashee Investment Management LLC 99,998$431,0000.07%
Governors Lane LP 196,034$845,0000.06%
SPHERA FUNDS MANAGEMENT LTD. 166,332$702,0000.05%
Context Capital Management, LLC 82,868$357,0000.04%
EQUITEC SPECIALISTS, LLC 35,825$154,0000.03%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 166,666$718,0000.02%
RA Capital Management 233,333$1,006,0000.02%
Logos Global Management LP 33,333$144,0000.01%
View complete list of CEREVEL THERAPEUTICS HLDNG I shareholders